Association of a Haplotype in the NR3C2 Gene, Encoding the Mineralocorticoid Receptor, With Chronic Central Serous Chorioretinopathy

被引:62
作者
van Dijk, Elon H. C. [1 ]
Schellevis, Rosa L. [2 ]
van Bergen, Maaike G. J. M. [2 ]
Breukink, Myrte B. [2 ]
Altay, Lebriz [3 ]
Scholz, Paula [3 ]
Fauser, Sascha [3 ]
Meijer, Onno C. [4 ,5 ]
Hoyng, Carel B. [2 ]
den Hollander, Anneke I. [2 ,6 ]
Boon, Camiel J. F. [1 ,7 ]
de Jong, Eiko K. [2 ]
机构
[1] Leiden Univ, Dept Ophthalmol, Med Ctr, Leiden, Netherlands
[2] Radboud Univ Nijmegen Med Ctr, Dept Ophthalmol, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands
[3] Univ Hosp Cologne, Dept Ophthalmol, Cologne, Germany
[4] Leiden Univ, Med Ctr, Dept Med, Div Endocrinol & Metab, Leiden, Netherlands
[5] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands
[6] Radboud Univ Nijmegen Med Ctr, Dept Human Genet, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands
[7] Univ Amsterdam, Acad Med Ctr, Dept Ophthalmol, Amsterdam, Netherlands
关键词
POLYMORPHISM; CORTICOSTEROIDS; IDENTIFICATION; SENSITIVITY; EPLERENONE; VARIANTS;
D O I
10.1001/jamaophthalmol.2017.0245
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
IMPORTANCE Chronic central serous chorioretinopathy (cCSC) is a chorioretinal disease with unknown disease etiology. The glucocorticoid receptor and the mineralocorticoid receptor, 2 glucocorticoid-binding receptors, might be involved in the pathogenesis of cCSC. OBJECTIVE To assess the association of functional variants and haplotypes in the glucocorticoid receptor (NR3C1) and mineralocorticoid receptor (NR3C2) genes with cCSC. DESIGN, SETTING, AND PARTICIPANTS In this case-control genetic association study, 336 patients with cCSC and 1314 unaffected controls, collected at 3 university medical centers from September 1, 2009, to May 1, 2016, underwent KASP genotyping for selected variants in NR3C1 (rs56149945, rs41423247, and rs6198) and NR3C2 (rs2070951 and rs5522). MAIN OUTCOMES AND MEASURES Genetic associations of 3 NR3C1 variants and 2 NR3C2 variants with cCSC. RESULTS Among the 336 patients (274 men and 62 women; mean [ SD] age, 52 [10] years), after correction for multiple testing, rs2070951 in the NR3C2 gene was significantly associated with cCSC (odds ratio, 1.29; 95% CI, 1.08-1.53; P = .004). Moreover, the GA haplotype of single-nucleotide polymorphisms rs2070951 and rs5522 in NR3C2 conferred risk for cCSC (odds ratio, 1.39; 95% CI, 1.15-1.68; P = .004), whereas the CA haplotype decreased risk for cCSC (odds ratio, 0.72; 95% CI, 0.60-0.87; P < .001). Three known variants in NR3C1 that alter the activity of the glucocorticoid receptor (rs56149945, rs41423247, and rs6198) were not associated with cCSC. CONCLUSIONS AND RELEVANCE In this study, the variant rs2070951 and the GA haplotype in NR3C2 were associated with an increased risk for cCSC. Results of this genetic study support a possible role for the mineralocorticoid receptor in the pathogenesis of cCSC. Since these haplotypes have previously been associated with perceived stress, this study provides a clue to bridging clinical risk factors for cCSC to underlying genetic associations.
引用
收藏
页码:446 / 451
页数:6
相关论文
共 45 条
[1]   World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects [J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (20) :2191-2194
[2]   SPIRONOLACTONE FOR NONRESOLVING CENTRAL SEROUS CHORIORETINOPATHY A Randomized Controlled Crossover Study [J].
Bousquet, Elodie ;
Beydoun, Talal ;
Rothschild, Pierre-Raphael ;
Bergin, Ciara ;
Zhao, Min ;
Batista, Rui ;
Brandely, Marie-Laure ;
Couraud, Benedicte ;
Farman, Nicolette ;
Gaudric, Alain ;
Chast, Francois ;
Behar-Cohen, Francine .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (12) :2505-2515
[3]   MINERALOCORTICOID RECEPTOR ANTAGONISM IN THE TREATMENT OF CHRONIC CENTRAL SEROUS CHORIORETINOPATHY A Pilot Study [J].
Bousquet, Elodie ;
Beydoun, Talal ;
Zhao, Min ;
Hassan, Leila ;
Offret, Olivier ;
Behar-Cohen, Francine .
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2013, 33 (10) :2096-2102
[4]   CENTRAL SEROUS CHORIORETINOPATHY IN ENDOGENOUS HYPERCORTISOLISM [J].
BOUZAS, EA ;
SCOTT, MH ;
MASTORAKOS, G ;
CHROUSOS, GP ;
KAISERKUPFER, MI .
ARCHIVES OF OPHTHALMOLOGY, 1993, 111 (09) :1229-1233
[5]   Genomic Copy Number Variations of the Complement Component C4B Gene Are Associated With Chronic Central Serous Chorioretinopathy [J].
Breukink, Myrte B. ;
Schellevis, Rosa L. ;
Boon, Camiel J. F. ;
Fauser, Sascha ;
Hoyng, Carel B. ;
den Hollander, Anneke I. ;
de Jong, Eiko K. .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (09) :5608-5613
[6]   The use of eplerenone in therapy-resistant chronic central serous chorioretinopathy [J].
Breukink, Myrte B. ;
den Hollander, Anneke I. ;
Keunen, Jan E. E. ;
Boon, Camiel J. F. ;
Hoyng, Carel B. .
ACTA OPHTHALMOLOGICA, 2014, 92 (06) :E488-E490
[7]   Clinical experience with eplerenone to treat chronic central serous chorioretinopathy [J].
Cakir, Bertan ;
Fischer, Franziska ;
Ehlken, Christoph ;
Buehler, Anima ;
Stahl, Andreas ;
Schlunck, Guenther ;
Boehringer, Daniel ;
Agostini, Hansjuergen ;
Lange, Clemens .
GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2016, 254 (11) :2151-2157
[8]   Corticosteroids and central serous chorioretinopathy [J].
Carvalho-Recchia, CA ;
Yannuzzi, LA ;
Negrao, S ;
Spaide, RF ;
Freund, KB ;
Rodriguez-Coleman, H ;
Lenharo, M ;
Iida, T .
OPHTHALMOLOGY, 2002, 109 (10) :1834-1837
[9]  
Conrad R, 2000, OPHTHALMOLOGE, V97, P527, DOI 10.1007/s003470070059
[10]   Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis [J].
Daruich, Alejandra ;
Matet, Alexandre ;
Dirani, Ali ;
Bousquet, Elodie ;
Zhao, Min ;
Farman, Nicolette ;
Jaisser, Frederic ;
Behar-Cohen, Francine .
PROGRESS IN RETINAL AND EYE RESEARCH, 2015, 48 :82-118